SA
ORCL logo
Oracle Corporation(ORCL)
Closing price · checked 10:11 AM ETAbout this dataData status
$101.19▼-9.38 (-8.49%)
Extended:$103.29+2.10 (+2.08%)· 10:11 AM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Oracle Corporation (ORCL)

Interest Coverage

4.55×

TTM · Retrieved:

ORCL logo

ORCL Interest Coverage

Current (TTM)4.55×
ORCL Interest Coverage (0.00× → 4.55×)
High-resolution chart · PNG

What is interest coverage?

Interest coverage ratio.

ORCL interest coverage history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Oracle Corporation Interest Coverage — Annual fiscal periods
Period endingInterest CoverageChange
4.5189×−8.54%
4.9407×+13.08%
4.3691×+16.96%
3.7355×−5.81%
3.9659×−34.93%
6.095×−12.50%
6.9654×+7.14%
6.501×−0.75%
6.5501×−8.80%
7.1819×−16.41%
8.5917×−29.20%
12.1356×−24.85%
16.1477×−10.83%
18.1079×+1.20%
17.893×+20.15%
14.8923×+23.91%
12.0186×−9.00%
13.2079×−33.66%
19.9086×—
0×—
0×—
0×—
0×—
0×—
0×—
0×—
0×—
0×—
0×—
0×—
0×—
0×—
0×—
0×—
0×—
0×—
0×—
0×—
0×—
0×—
0×—

Frequently asked questions: ORCL interest coverage

What is Oracle Corporation (ORCL)'s current interest coverage?

Oracle Corporation (ORCL)'s latest reported interest coverage (TTM) is 4.55× as of Nov 21, 2026. Interest coverage ratio.

How much historical interest coverage data is available for ORCL?

Stock Alarm Pro provides 41 dated annual fiscal periods observations for Oracle Corporation (ORCL)'s interest coverage, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare ORCL's interest coverage to peers or set an alert?

You can open ORCL's interest coverage in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on ORCL delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.